Amit Mehra Joins OXON Technologies as Senior Advisor to Boost Climate-Tech Initiatives
July 25, 2025 - 23:43
LONDON, UK – OXON Technologies, a leader in deep-tech innovations aimed at enhancing fuel efficiency and reducing industrial emissions, has announced the appointment of Amit Mehra as Senior Advisor. This strategic move is designed to accelerate the commercialization of climate-tech solutions that address pressing environmental challenges.
Amit Mehra brings a wealth of experience in global business and technology leadership, having worked with various organizations to drive sustainable growth and innovation. His expertise will be instrumental in guiding OXON Technologies as it seeks to expand its market reach and develop groundbreaking technologies that promote decarbonization.
The company is committed to pioneering advancements that not only improve operational efficiencies but also contribute to the global fight against climate change. With Mehra’s leadership, OXON Technologies aims to enhance its strategic initiatives, fostering collaborations that will lead to impactful climate solutions.
As the world increasingly prioritizes sustainability, OXON Technologies is poised to play a crucial role in shaping the future of climate-tech.
MORE NEWS
July 25, 2025 - 13:02
Celebrating Excellence: Colorado's Top CIOs Acknowledged at 2025 ORBIE AwardsDENVER, July 24, 2025 — The 2025 Colorado ORBIE Awards have celebrated the outstanding achievements of leading technology executives who have made significant impacts in their organizations. This...
July 24, 2025 - 18:18
Innovative Surveillance Technology Tracks Individuals via Wi-Fi Signal DisruptionHi-tech surveillance technologies are a double-edged sword. On one hand, there is a desire for sophisticated devices that can detect suspicious behavior and alert authorities. On the other, there...
July 24, 2025 - 02:27
Marvell Technology Positioned for Growth in AI InfrastructureMarvell Technology, Inc. has emerged as a leading player in the AI sector, showcasing significant upside potential. Recently, a prominent financial firm reaffirmed its confidence in Marvell,...
July 23, 2025 - 04:34
FDA Suspends Sarepta's Gene Therapy Designation Amid Safety ConcernsThe FDA has officially revoked the designation for Sarepta’s gene therapy platform technology aimed at treating muscular dystrophy, following a series of patient fatalities linked to its clinical...